Annual Net Income
-$48.93 M
-$6.73 M-15.94%
December 31, 2023
Summary
- As of February 7, 2025, HEPA annual net profit is -$48.93 million, with the most recent change of -$6.73 million (-15.94%) on December 31, 2023.
- During the last 3 years, HEPA annual net income has fallen by -$28.57 million (-140.38%).
- HEPA annual net income is now -826.49% below its all-time high of -$5.28 million, reached on June 30, 2014.
Performance
HEPA Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Net Income
-$4.87 M
-$940.70 K-23.97%
September 30, 2024
Summary
- As of February 7, 2025, HEPA quarterly net profit is -$4.87 million, with the most recent change of -$940.70 thousand (-23.97%) on September 30, 2024.
- Over the past year, HEPA quarterly net income has increased by +$5.66 million (+53.78%).
- HEPA quarterly net income is now -211.07% below its all-time high of $4.38 million, reached on June 30, 2014.
Performance
HEPA Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Net Income
-$22.70 M
+$5.66 M+19.96%
September 30, 2024
Summary
- As of February 7, 2025, HEPA TTM net profit is -$22.70 million, with the most recent change of +$5.66 million (+19.96%) on September 30, 2024.
- Over the past year, HEPA TTM net income has increased by +$21.97 million (+49.18%).
- HEPA TTM net income is now -1445.93% below its all-time high of $1.69 million, reached on September 1, 2011.
Performance
HEPA TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Net Income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
HEPA Net Income Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -15.9% | +53.8% | +49.2% |
| 3 y3 years | -140.4% | +50.0% | +30.6% |
| 5 y5 years | -417.8% | +50.0% | +30.6% |
HEPA Net Income Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -49.5% | at low | -70.5% | +75.6% | at high | +53.6% |
| 5 y | 5-year | -595.2% | at low | -119.9% | +75.6% | -222.6% | +53.6% |
| alltime | all time | -826.5% | at low | -211.1% | +75.6% | -1445.9% | +53.6% |
Hepion Pharmaceuticals Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$4.87 M(+24.0%) | -$22.70 M(-20.0%) |
| Jun 2024 | - | -$3.93 M(+37.5%) | -$28.37 M(-26.4%) |
| Mar 2024 | - | -$2.85 M(-74.2%) | -$38.52 M(-21.3%) |
| Dec 2023 | -$48.93 M(+15.9%) | -$11.06 M(+5.1%) | -$48.93 M(+9.5%) |
| Sep 2023 | - | -$10.53 M(-25.2%) | -$44.68 M(+4.6%) |
| Jun 2023 | - | -$14.08 M(+6.2%) | -$42.70 M(-12.0%) |
| Mar 2023 | - | -$13.26 M(+94.7%) | -$48.53 M(+15.0%) |
| Dec 2022 | -$42.20 M(+29.0%) | -$6.81 M(-20.3%) | -$42.20 M(-6.5%) |
| Sep 2022 | - | -$8.55 M(-57.1%) | -$45.11 M(-1.6%) |
| Jun 2022 | - | -$19.91 M(+187.3%) | -$45.83 M(+36.5%) |
| Mar 2022 | - | -$6.93 M(-28.7%) | -$33.59 M(+2.6%) |
| Dec 2021 | -$32.72 M(+60.8%) | -$9.72 M(+4.9%) | -$32.72 M(+17.0%) |
| Sep 2021 | - | -$9.27 M(+20.9%) | -$27.96 M(+12.2%) |
| Jun 2021 | - | -$7.67 M(+26.4%) | -$24.92 M(+12.3%) |
| Mar 2021 | - | -$6.06 M(+22.4%) | -$22.19 M(+9.0%) |
| Dec 2020 | -$20.35 M(+189.2%) | -$4.96 M(-20.5%) | -$20.35 M(+15.6%) |
| Sep 2020 | - | -$6.23 M(+26.1%) | -$17.61 M(+33.4%) |
| Jun 2020 | - | -$4.94 M(+16.9%) | -$13.20 M(+42.2%) |
| Mar 2020 | - | -$4.23 M(+91.0%) | -$9.28 M(+31.9%) |
| Dec 2019 | -$7.04 M(-25.5%) | -$2.21 M(+21.6%) | -$7.04 M(-4.9%) |
| Sep 2019 | - | -$1.82 M(+78.2%) | -$7.40 M(+29.0%) |
| Jun 2019 | - | -$1.02 M(-48.5%) | -$5.73 M(-34.4%) |
| Mar 2019 | - | -$1.98 M(-22.9%) | -$8.74 M(-7.5%) |
| Dec 2018 | -$9.45 M(+25.8%) | -$2.57 M(+1537.6%) | -$9.45 M(+37.4%) |
| Sep 2018 | - | -$157.10 K(-96.1%) | -$6.88 M(-45.0%) |
| Jun 2018 | - | -$4.03 M(+49.8%) | -$12.49 M(+94.8%) |
| Mar 2018 | - | -$2.69 M(-53.4%) | -$6.41 M(-59.5%) |
| Dec 2017 | -$7.51 M | - | - |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2017 | - | -$5.77 M(-381.7%) | -$15.85 M(+6.4%) |
| Jun 2017 | -$14.89 M(-12.4%) | $2.05 M(-126.9%) | -$14.89 M(-32.8%) |
| Mar 2017 | - | -$7.62 M(+69.1%) | -$22.15 M(+20.1%) |
| Dec 2016 | - | -$4.51 M(-6.5%) | -$18.45 M(+8.7%) |
| Sep 2016 | - | -$4.82 M(-7.5%) | -$16.97 M(-0.2%) |
| Jun 2016 | -$17.00 M(+18.5%) | -$5.21 M(+32.9%) | -$17.00 M(-1.0%) |
| Mar 2016 | - | -$3.92 M(+29.3%) | -$17.17 M(-2.7%) |
| Dec 2015 | - | -$3.03 M(-37.4%) | -$17.65 M(-0.4%) |
| Sep 2015 | - | -$4.84 M(-9.9%) | -$17.72 M(+23.5%) |
| Jun 2015 | -$14.35 M(+171.7%) | -$5.38 M(+22.2%) | -$14.35 M(+212.5%) |
| Mar 2015 | - | -$4.40 M(+41.7%) | -$4.59 M(-51.7%) |
| Dec 2014 | - | -$3.10 M(+111.1%) | -$9.51 M(+44.7%) |
| Sep 2014 | - | -$1.47 M(-133.6%) | -$6.57 M(+24.4%) |
| Jun 2014 | -$5.28 M | $4.38 M(-147.0%) | -$5.28 M(-45.3%) |
| Mar 2014 | - | -$9.31 M(+5436.1%) | -$9.66 M(+2658.2%) |
| Dec 2013 | - | -$168.20 K(-7.6%) | -$350.30 K(+92.4%) |
| Sep 2013 | - | -$182.10 K(<-9900.0%) | -$182.10 K(-136.8%) |
| Dec 2011 | - | $0.00(-100.0%) | $495.10 K(-70.7%) |
| Sep 2011 | - | $494.40 K(>+9900.0%) | $1.69 M(+37.9%) |
| Jun 2011 | - | $0.00(-100.0%) | $1.22 M(-3.2%) |
| Mar 2011 | - | $700.00(-99.9%) | $1.26 M(-10.0%) |
| Dec 2010 | - | $1.19 M(+3744.5%) | $1.40 M(+195.4%) |
| Sep 2010 | - | $31.00 K(-22.7%) | $475.30 K(-43.6%) |
| Jun 2010 | - | $40.10 K(-71.5%) | $842.60 K(+2.1%) |
| Mar 2010 | - | $140.90 K(-46.5%) | $825.60 K(+14.3%) |
| Dec 2009 | - | $263.30 K(-33.9%) | $722.40 K(+57.4%) |
| Sep 2009 | - | $398.30 K(+1624.2%) | $459.10 K(+655.1%) |
| Jun 2009 | - | $23.10 K(-38.7%) | $60.80 K(+61.3%) |
| Mar 2009 | - | $37.70 K | $37.70 K |
FAQ
- What is Hepion Pharmaceuticals annual net profit?
- What is the all time high annual net income for Hepion Pharmaceuticals?
- What is Hepion Pharmaceuticals annual net income year-on-year change?
- What is Hepion Pharmaceuticals quarterly net profit?
- What is the all time high quarterly net income for Hepion Pharmaceuticals?
- What is Hepion Pharmaceuticals quarterly net income year-on-year change?
- What is Hepion Pharmaceuticals TTM net profit?
- What is the all time high TTM net income for Hepion Pharmaceuticals?
- What is Hepion Pharmaceuticals TTM net income year-on-year change?
What is Hepion Pharmaceuticals annual net profit?
The current annual net income of HEPA is -$48.93 M
What is the all time high annual net income for Hepion Pharmaceuticals?
Hepion Pharmaceuticals all-time high annual net profit is -$5.28 M
What is Hepion Pharmaceuticals annual net income year-on-year change?
Over the past year, HEPA annual net profit has changed by -$6.73 M (-15.94%)
What is Hepion Pharmaceuticals quarterly net profit?
The current quarterly net income of HEPA is -$4.87 M
What is the all time high quarterly net income for Hepion Pharmaceuticals?
Hepion Pharmaceuticals all-time high quarterly net profit is $4.38 M
What is Hepion Pharmaceuticals quarterly net income year-on-year change?
Over the past year, HEPA quarterly net profit has changed by +$5.66 M (+53.78%)
What is Hepion Pharmaceuticals TTM net profit?
The current TTM net income of HEPA is -$22.70 M
What is the all time high TTM net income for Hepion Pharmaceuticals?
Hepion Pharmaceuticals all-time high TTM net profit is $1.69 M
What is Hepion Pharmaceuticals TTM net income year-on-year change?
Over the past year, HEPA TTM net profit has changed by +$21.97 M (+49.18%)